Signos Acquired | Healthcare M&A Deal

Signos has completed the acquisition of Signos, a medical devices business in California, for $20M. Signos develops a continuous glucose monitoring platform that pairs over-the-counter CGM with an app translating glucose readings into personalized diet and lifestyle guidance for weight loss. The company’s technology supports CGM use beyond diabetes by turning real-time glucose data into actionable recommendations for consumers and clinicians. The healthcare M&A deal is categorized as other acquisition, with funding announced at $20M to expand commercialization, and it is expected to accelerate adoption of CGM-enabled weight management.